In this study, dexmedetomidine, medetomidine, morphine and butorphanol combined with ketamine, the
general anesthetic drug, has been used in clinical and experimental studies in order to achieve equilibrium
anesthesia in desired duration and quality. The effects of the use of these drugs in various combinations on
clinical and blood parameters were investigated. Twentyfour healthy adult cats were used in 4 groups.
Subjects were evaluated in terms of clinical (respiratory rate, heart rate, blood pressure, capillary filling
time, body temperature, conjunctival color, dehydration status), and hematological parameters. Six cats in
the first group were treated with dexmedetomidine 0.01 mg/kg IM, then butorphanol 0.2 mg/kg SC and 10
minutes after 5 mg/kg IM ketamine was administered and the patients were intubated. Medetomidine 0.02
mg/kg IM was administered to in the second group, then butorphanol 0.2 mg/kg IM and 5 mg/kg IM
ketamine was administered after 10 minutes and the patients were intubated. Dexmedetomidine 0.01 mg/
kg IM was administered to in the third group, then morphine 0.1 mg/kg IM and 5 mg/kg IM after 10
minutes, and the patients were intubated. Medetomidine 0.02 mg/kg IM was administered to in the fourth
group, then morphine 0.1 mg/kg IM and ketamine at a dose of 5 mg/kg IM 10 minutes after intubation.
Onset of swallowing, onset of first movement, perception of sound and raising the head, sitting position
and standing up, walking without coordination were realized in the third group at the earliest. It was
determined that the best result was observed in the 3rd group during the awakening period. When the
hematological data, respiratory, cardiologic and awakening periods were evaluated, it was found that the
best data were in the dexmedetomidine and butorphanol group.
Primary Language | English |
---|---|
Subjects | Veterinary Surgery |
Journal Section | Research Articles |
Authors | |
Publication Date | March 31, 2020 |
Published in Issue | Year 2020 Vetexpo-2019, KHVD-2019 |
CC-BY
This journal is presented to the reader under Creative Commons attribution 4.0 international (CC-BY 4.0)